Algert Global LLC Sells 66,041 Shares of Select Medical Holdings Co. (NYSE:SEM)

Algert Global LLC lessened its stake in Select Medical Holdings Co. (NYSE:SEM - Free Report) by 74.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 22,550 shares of the health services provider's stock after selling 66,041 shares during the period. Algert Global LLC's holdings in Select Medical were worth $786,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in SEM. Tidal Investments LLC acquired a new stake in Select Medical in the first quarter worth $467,000. Comerica Bank lifted its position in Select Medical by 30.0% in the 1st quarter. Comerica Bank now owns 68,485 shares of the health services provider's stock valued at $2,065,000 after purchasing an additional 15,824 shares during the last quarter. Boston Partners acquired a new position in Select Medical during the 1st quarter valued at about $718,000. GAMMA Investing LLC increased its stake in shares of Select Medical by 52.8% in the second quarter. GAMMA Investing LLC now owns 1,983 shares of the health services provider's stock valued at $70,000 after purchasing an additional 685 shares during the period. Finally, Linden Thomas Advisory Services LLC raised its holdings in shares of Select Medical by 9.2% during the second quarter. Linden Thomas Advisory Services LLC now owns 18,938 shares of the health services provider's stock valued at $664,000 after buying an additional 1,601 shares during the last quarter. 89.48% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, Director Marilyn B. Tavenner sold 32,000 shares of Select Medical stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total value of $674,880.00. Following the completion of the sale, the director now directly owns 22,000 shares in the company, valued at approximately $463,980. The trade was a 59.26 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 19.14% of the stock is owned by corporate insiders.

Select Medical Stock Up 3.7 %

Shares of NYSE:SEM traded up $0.76 during trading on Friday, hitting $21.11. 1,201,407 shares of the company's stock traded hands, compared to its average volume of 634,308. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. The company has a market cap of $2.73 billion, a price-to-earnings ratio of 9.86, a price-to-earnings-growth ratio of 0.91 and a beta of 1.42. The company has a 50-day moving average price of $34.11 and a 200-day moving average price of $34.71. Select Medical Holdings Co. has a 52 week low of $20.00 and a 52 week high of $40.98.

Select Medical (NYSE:SEM - Get Free Report) last announced its earnings results on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, topping the consensus estimate of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The business had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.74 billion. During the same quarter in the prior year, the company posted $0.46 earnings per share. The firm's revenue was up 5.7% on a year-over-year basis. As a group, research analysts forecast that Select Medical Holdings Co. will post 2.16 EPS for the current fiscal year.

Select Medical Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th were issued a $0.125 dividend. This represents a $0.50 annualized dividend and a dividend yield of 2.37%. The ex-dividend date of this dividend was Wednesday, November 13th. Select Medical's payout ratio is presently 23.36%.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on SEM. Royal Bank of Canada lifted their target price on shares of Select Medical from $40.00 to $47.00 and gave the stock an "outperform" rating in a research report on Monday, November 4th. Bank of America initiated coverage on Select Medical in a research report on Tuesday, August 20th. They set a "buy" rating and a $42.00 price objective for the company. StockNews.com lowered shares of Select Medical from a "buy" rating to a "hold" rating in a research note on Thursday, November 21st. Finally, Benchmark downgraded shares of Select Medical from a "buy" rating to a "hold" rating in a report on Monday, November 25th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $40.75.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.